Active substances
Dextrose + Potassium chloride + Sodium chloride
- SFDA 6
- US FDA 129
- Health Canada 7
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| 0.075% POTASSIUM CHLORIDE in 5% DEXTROSE and 0.45% SODIUM CHLORIDE Injection USP | 5,0.45,0.075 %,%,% | Solution for infusion · Intravenous use | 1 Bag | SAR 18.00 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| POTASSIUM CHLORIDE in DEXTROSE and SODIUM CHLORIDE Injection USP | 5,0.2,0.15 %,%,% | Solution · Intravenous use | 1 Bag | SAR 31.60 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| POTASSIUM CHLORIDE in DEXTROSE and SODIUM CHLORIDE Injection USP | 5,0.45,0.15 %,%,% | Solution · Intravenous use | 1 Bag | SAR 31.60 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| POTASSIUM CHLORIDE in DEXTROSE and SODIUM CHLORIDE Injection USP | 5,0.45,0.15 %,%,% | Solution · Intravenous use | 1 Bag | SAR 18.00 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| Potassium Chloride in Dextrose and Sodium Chloride Injection USP | 5,0.45,0.3 %,%,% | Intravenous infusion · Intravenous use | 1 Bottle | SAR 18.00 | Generic · Prescription | AL RAZI PHARMA INDUSTRIES | Valid |
| Potassium Chloride in Dextrose and Sodium Chloride Injection USP | 5,0.45,0.15 %,%,% | Intravenous infusion · Intravenous use | 1 Bottle | SAR 18.00 | Generic · Prescription | AL RAZI PHARMA INDUSTRIES | Valid |
Indications — CHI Daman Drug Formulary
FLUIDS AND VOLUME EXPANDERS-MAINTENANCE FLUIDS
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER | 5GM/100ML;150MG/100ML;450MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 2 Feb 1979 |
| POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER | 5GM/100ML;75MG/100ML;450MG/100ML; 5GM/100ML;150MG/100ML;450MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 2 Feb 1979 |
| POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER | 5GM/100ML;150MG/100ML;450MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 2 Feb 1979 |
| POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER | 5GM/100ML;224MG/100ML;450MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 2 Feb 1979 |
| POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER | 5GM/100ML;300MG/100ML;450MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 2 Feb 1979 |
| DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER | 5GM/100ML;300MG/100ML;450MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 2 Feb 1979 |
| DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K) | 5GM/100ML;300MG/100ML;200MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 2 Feb 1979 |
| DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ | 5GM/100ML;75MG/100ML;200MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 2 Feb 1979 |
| DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (K) | 5GM/100ML;150MG/100ML;200MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 2 Feb 1979 |
| DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 15MEQ (K) | 5GM/100ML;224MG/100ML;200MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 2 Feb 1979 |
| DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 30MEQ | 5GM/100ML;224MG/100ML;200MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 2 Feb 1979 |
| DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ | 5GM/100ML;75MG/100ML;200MG/100ML; 5GM/100ML;150MG/100ML;200MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 2 Feb 1979 |
| DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ | 5GM/100ML;150MG/100ML;200MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 2 Feb 1979 |
| DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ | 5GM/100ML;300MG/100ML;200MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 2 Feb 1979 |
| POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER | 5GM/100ML;224MG/100ML;450MG/100ML | injectable · injection | OTSUKA ICU MEDCL | Prescription | 29 May 1980 |
| POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER | 5GM/100ML;298MG/100ML;450MG/100ML | injectable · injection | OTSUKA ICU MEDCL | Prescription | 29 May 1980 |
| POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER | 5GM/100ML;149MG/100ML;450MG/100ML; 5GM/100ML;74.5MG/100ML;450MG/100ML | injectable · injection | OTSUKA ICU MEDCL | Prescription | 29 May 1980 |
| POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER | 5GM/100ML;149MG/100ML;450MG/100ML | injectable · injection | OTSUKA ICU MEDCL | Prescription | 29 May 1980 |
| POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER | 5GM/100ML;149MG/100ML;225MG/100ML | injectable · injection | OTSUKA ICU MEDCL | Prescription | 29 May 1980 |
| DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER | 5GM/100ML;75MG/100ML;330MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 23 Mar 1982 |
| DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER | 5GM/100ML;150MG/100ML;330MG/100ML; 5GM/100ML;75MG/100ML;330MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 23 Mar 1982 |
| DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER | 5GM/100ML;224MG/100ML;330MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 23 Mar 1982 |
| DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER | 5GM/100ML;150MG/100ML;330MG/100ML; 5GM/100ML;300MG/100ML;330MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 23 Mar 1982 |
| DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER | 5GM/100ML;224MG/100ML;330MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 23 Mar 1982 |
| DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER | 5GM/100ML;300MG/100ML;330MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 23 Mar 1982 |
104 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| (20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP | 00438014 | 3.3 G / 100 ML; 150 MG / 100 ML; 300 MG / 100 ML | SOLUTION · INTRAVENOUS | BAXTER CORPORATION |
| (20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP | 00786292 | 5 G / 100 ML; 900 MG / 100 ML; 150 MG / 100 ML | SOLUTION · INTRAVENOUS | BAXTER CORPORATION |
| (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP | 00437999 | 450 MG / 100 ML; 150 MG / 100 ML; 5 G / 100 ML | SOLUTION · INTRAVENOUS | BAXTER CORPORATION |
| (40MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP | 00438022 | 300 MG / 100 ML; 300 MG / 100 ML; 3.3 G / 100 ML | SOLUTION · INTRAVENOUS | BAXTER CORPORATION |
| (40MMOL/L)POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP | 00438006 | 300 MG / 100 ML; 450 MG / 100 ML; 5 G / 100 ML | SOLUTION · INTRAVENOUS | BAXTER CORPORATION |
| 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USP | 01931598 | 5 G / 100 ML; 200 MG / 100 ML; 150 MG / 100 ML | SOLUTION · INTRAVENOUS | B. BRAUN MEDICAL INC |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 00786306 | 900 MG / 100 ML; 300 MG / 100 ML; 5 G / 100 ML | SOLUTION · INTRAVENOUS | BAXTER CORPORATION |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.